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        Introduction 
  Cdks are heterodimeric enzymes with one catalytic and one regu-
latory subunit. Dimerization of these two subunits is essential for 
kinase activity. As the name suggests, some of the regulatory sub-
units are cyclins, including cyclin E and A, that are synthesized in 
a  cell  cycle – dependent  manner.  These  cyclin – Cdk  complexes 
play essential roles in controlling different phases of and the pro-
gression through the cell cycle (  Nurse, 2000  ;   Sherr and Roberts, 
2004  ). However, other regulatory subunits have been identifi  ed 
that are expressed and function independently of the cell cycle 
(  Nebreda, 2006  ). These include T-type cyclins and cyclin K, 
which associate with Cdk9 to form distinct positive transcription 
elongation factor b complexes and cyclin H – Cdk7, which are part 
of the general transcription factor complex transcription factor II H. 
These kinases are critical in regulating distinct steps in tran-
scription, including the phosphorylation of components of the 
mediator complex and the catalytic subunit of the RNA polymer-
ase II complex (  Zurita and Merino, 2003  ;   Marshall and Grana, 
2006  ). Furthermore, Cdk5 associates with two regulatory subunits, 
p35 and 39, and these complexes are expressed primarily in post-
mitotic neurons as well as in other nonproliferating cells. Cdk5 
has been attributed key functions during brain development, in-
cluding regulation of neuronal survival, cell migration during corti-
cal layering, neurite outgrowth, axon guidance, and synapse function 
(  Dhavan and Tsai, 2001  ;   Nikolic, 2004  ;   Xie et al., 2006  ). 
  To obtain further insight into the role of Cdk-dependent 
regulation of cellular processes, we sought to identify novel 
substrates for such kinases. We chose cyclin E  –  Cdk2 because 
this kinase is an important regulator of the G1 to S-phase transi-
tion and is deregulated in a substantial fraction of human tumors 
(  Musgrove, 2006  ). Indeed, elevated cyclin E expression has been 
linked to a poor prognosis in human breast cancer (  Keyomarsi 
et al., 2003  ). Furthermore, the cyclin E  –  Cdk2 kinase is activated 
C
yclin-dependent kinases (Cdks) fulﬁ  ll key functions 
in many cellular processes, including cell cycle 
progression and cytoskeletal dynamics. A limited 
number of Cdk substrates have been identiﬁ   ed with 
few demonstrated to be regulated by Cdk-dependent 
phosphorylation. We identify on protein expression ar-
rays novel cyclin E  –  Cdk2 substrates, including SIRT2, a 
member of the Sirtuin family of NAD 
+  -dependent deacet-
ylases that targets      -tubulin. We deﬁ  ne Ser-331 as the 
site phosphorylated by cyclin E  –  Cdk2, cyclin A  –  Cdk2, 
and p35  –  Cdk5 both in vitro and in cells. Importantly, 
phosphorylation at Ser-331 inhibits the catalytic activity 
of SIRT2. Gain- and loss-of-function studies demonstrate 
that SIRT2 interfered with cell adhesion and cell migration. 
In postmitotic hippocampal neurons, neurite outgrowth 
and growth cone collapse are inhibited by SIRT2. The effects 
provoked by SIRT2, but not those of a nonphosphorylatable 
mutant, are antagonized by Cdk-dependent phosphory-
lation. Collectively, our ﬁ  ndings identify a posttranslational 
mechanism that controls SIRT2 function, and they provide 
evidence for a novel regulatory circuitry involving Cdks, 
SIRT2, and microtubules.
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with recombinant baculoviral cyclin E  –  Cdk2 and     -[ 
32 P]ATP 
( Fig.  1  A  ).   The clones corresponding to 96 prominent substrates 
were sequenced and revealed 42 clones that expressed the ORF 
in frame with the N-terminal tag. These represented 26 different 
proteins, some known Cdk substrates, with potential phosphory-
lation sites and cyclin binding motifs ( Table I ).    These substrates, 
bacterially expressed HIS or GST fusion proteins, were verifi  ed 
in in vitro kinase assays using different cyclin  –  Cdk complexes. 
Similar amounts of kinase activities were used as assessed with 
Rb and histone H1 as substrates (  Fig. 1   B    ). All proteins identi-
fi  ed in the screen, except one (RPL14), were phosphorylated by 
cyclin E  –  Cdk2, demonstrating that these are true positive in vitro 
substrates (  Table I   and Fig. S1, available at http://www.jcb
.org/cgi/content/full/jcb.200707126/DC1). As expected, many 
of the cyclin E  –  Cdk2 substrates were also phosphorylated by 
cyclin A  –  Cdk2 and, strikingly, by cyclin D3  –  Cdk4 but not by 
cyclin B  –  Cdk1 or cyclin D1  –  Cdk4 (  Table I   and Fig. S1). 
We observed cyclin D3 phosphorylation of the purifi  ed cyclin D3  – 
Cdk4 complex (  Fig. 1,   B   and C  ; and Fig. S1), although D-type 
cyclins have not been described to be autophosphorylated. 
However, because this phosphorylation was completely repressed 
by p16 
INK4A  , an inhibitor of D-type kinase complexes, it is most 
likely mediated by Cdk4 (Fig. S1   A  ). In this paper, we chose 
to further investigate SIRT2, a member of the Sirtuin family of 
NAD 
+ -dependent  deacetylases. 
  Phosphorylation of SIRT2 by Cdks 
 The  fi  ndings from the screen were verifi  ed by phosphorylating 
a GST-SIRT2 fusion protein by the different purifi  ed kinase com-
plexes (  Fig. 1   and Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200707126/DC1). SIRT2 was a substrate for 
cyclin E  –  Cdk2 and, to a lesser extent, cyclin A  –  Cdk2 (  Fig. 1 C  ). 
In addition SIRT2 was weakly phosphorylated by cyclin D3  –
  Cdk4 and cyclin B  –  Cdk1 but not by cyclin D1  –  Cdk4 (  Fig. 1 C  ). 
Inspection of the human SIRT2 protein sequence revealed a sin-
gle consensus sequence for Cdks, S  331  PKK, which is C terminal 
of the catalytic domain (  Fig. 1   D    ) and is conserved in mouse 
SIRT2. Similar phosphorylation sites at comparable positions 
relative to the catalytic domains are found in the SIRT family 
members SIRT1, 6, and 7 (  Fig. 1   D    ) and are phosphorylated by 
Cdk2 in vitro (not depicted). To address whether S331 is phos-
phorylated by Cdk2, GST-SIRT2 fusion proteins with S331 mu-
tated to Ala, Asp, or Glu were phosphorylated with recombinant 
cyclin E  –  Cdk2 or cyclin A  –  Cdk2. Mutation of S331 abolished 
Cdk2-dependent phosphorylation (  Fig. 1   E    ; and Fig. S2, A  –  C). 
The reactions were specifi  c because roscovitine, a Cdk inhibi-
tor, abolished SIRT2 phosphorylation (Fig. S2,   A   and   C).   In ad-
dition, S331 phosphorylation by cyclin E  –  Cdk2 in vitro was 
confi  rmed by mass spectrometry analysis (Fig. S2   D  ). 
  SIRT2 is highly expressed in the nervous system (Fig. S3, 
available at http://www.jcb.org/cgi/content/full/jcb.200707126/
DC1), which is in agreement with previous reports (  Li et al., 
2007 ;   Southwood et al., 2007  ). Similarly, in the nervous system, 
Cdk5 is strongly expressed in postmitotic neuronal cells, unlike 
Cdk2, which is down-regulated when neurons exit the cell cycle 
and differentiate (  Freeman et al., 1994  ). Therefore, we tested 
whether a p35  –  Cdk5 complex could phosphorylate SIRT2. 
in response to several oncoproteins including MYC and the adeno-
viral E1A protein, supporting a role of this kinase in tumori-
genesis (  Amati et al., 1998  ;   Luscher, 2001  ). Among the cyclin E  – 
Cdk2 substrates are proteins controlling cell cycle progression, 
the centrosome cycle, replication, and several transcriptional 
regulators (  Malumbres and Barbacid, 2005  ). Cdk2 not only 
associates with cyclin E but also with cyclin A, and the two com-
plexes share several substrates. In addition, Cdk2 and 5 show 
similar substrate specifi  cities (  Dhavan and Tsai, 2001  ). In this 
paper we identify 26 cyclin E  –  Cdk2 substrates, including SIRT2, 
a member of the Sirtuin family that consists of seven members, 
SIRT1  –  7, in mammals (  Haigis and Guarente, 2006  ;   Michan and 
Sinclair, 2007 ). Sirtuins are class III histone deacetylases (HDAC) 
that require NAD 
+   as a cofactor and deacetylate Lys residues. 
Sirtuins can be found in different compartments within the cell 
regulating a variety of processes, including many aspects of 
transcription, the lifespan of organisms, neuroprotection, tumor 
suppression, differentiation, and infl  ammation (  Haigis and 
Guarente, 2006  ;   Michan and Sinclair, 2007  ). SIRT2 is the only 
Sirtuin family member that is preferentially localized in the cyto-
plasm but, in addition, has also been implicated in nuclear func-
tions (  Dryden et al., 2003  ;   North et al., 2003  ;   Vaquero et al., 
2006  ;   Wilson et al., 2006  ;   North and Verdin, 2007a  ). 
  Reversible acetylation of proteins at the      -amino group of 
Lys residues has been recognized as an important posttransla-
tional mechanism to control nuclear protein function, including 
histones and transcription factors (  Kouzarides, 2000  ). In contrast, 
relatively little is known about acetylation/deacetylation of pro-
teins outside the nucleus. Recent evidence, however, suggests 
that several cytoplasmic proteins are acetylated ( Kim et al., 2006 ). 
Most notably,      -tubulin is acetylated at Lys-40 (K40), a modifi  -
cation that has been suggested to enhance microtubule stability 
(  North et al., 2003  ). Although the acetyl transferases that mod-
ify K40 are not known, two deacetylases that physically inter-
act, SIRT2 and HDAC6, have been implicated in removing the 
modifi  cation (  Hubbert et al., 2002  ;   Dryden et al., 2003  ;   North 
et al., 2003  ;   Zhang et al., 2003  ). It has been suggested that 
SIRT2 affects progression through mitosis in response to stress 
and that SIRT2 is regulated in mitosis by phosphorylation (  Dryden 
et al., 2003  ;   Inoue et al., 2007  ;   North and Verdin, 2007b  ). 
  In this paper, we have identifi  ed in SIRT2 a single Cdk2 and 5 
phosphorylation site, Ser-331 (S331), C-terminal of the catalytic 
domain. Phosphorylation at S331 inhibits the enzymatic activity 
of SIRT2. The functional analysis of SIRT2 and phosphorylation 
site mutants revealed that this enzyme interferes with cell adhesion 
in tumor cells, cell migration in fi  broblasts, and neurite outgrowth 
and growth cone motility in neurons. Importantly, these SIRT2-
mediated effects are antagonized by Cdk-dependent phosphory-
lation at S331. Collectively, our fi  ndings defi  ne a posttranslational 
mechanism that regulates SIRT2 function both in vitro and in cells. 
  Results 
  Identiﬁ  cation of novel cyclin  –  Cdk 
substrates 
  To identify novel cyclin E  –  Cdk2 substrates, high-density protein 
arrays on polyvinylidine difl  uoride fi  lters were phosphorylated 917 CYCLIN-DEDENDENT KINASE  –  DEPENDENT REGULATION OF SIRT2   •   PANDITHAGE ET AL.
  Figure 1.       Identiﬁ  cation of SIRT2 as a Cdk substrate.   (  A  ) High-density protein arrays (two ﬁ  lters with 37,830 clones preselected for high protein expression 
by virtue of N-terminal 6xHIS tags [  Bussow et al., 1998  ]) were incubated with recombinant human cyclin E  –  Cdk2 and      -[ 
32  P]ATP, washed, and exposed to 
x-ray ﬁ  lm. Potential substrates appear as double spots, as indicated by circles. A portion of one ﬁ  lter is displayed. (  B  ) cyclin  –  Cdk complexes were incubated 
with or without their respective substrates (Cdk4 complexes with GST-pRb 
773-928   and Cdk2 and 1 complexes with histone H1) and      -[ 
32  P]ATP. Proteins were 
resolved by 7  –  17% SDS-PAGE and visualized by autoradiography ( 
32  P, top) or Coomassie blue staining (CB, bottom). Kinase complexes are abbrevi-
ated (e.g., D1  –  K4 for cyclin D1  –  Cdk4). (  C  ) Bacterially expressed GST-SIRT2 full-length fusion protein was phosphorylated with the indicated kinases as 
described in B. (D) Schematic comparison of   Saccharomyces cerevisiae   Sir2 with human SIRT1, 2, 6, and 7. The catalytic domains and the potential Cdk 
phosphorylation sites are indicated. (  E  ) Bacterially expressed GST-SIRT2 fusion proteins, as indicated, were phosphorylated with 25 fcatal cyclin E  –  Cdk2. 
GST and histone H1 served as controls. Protein analysis was performed as in B. (  F  ) The experiment was performed as in   E   with 3 fcatal of recombinant 
p35  –  Cdk5. For a control, 25   μ  M roscovitine was added to inhibit Cdk5 activity.     JCB • VOLUME 180 • NUMBER 5 • 2008  918
  Table I.       In vitro phosphorylation of potential cyclin E  –  Cdk2 substrates by different cyclin  –  Cdk complexes   
Potential cyclin E  –  Cdk2 substrate Phosphorylation  
  sites and cyclin  
  binding motifs in the RZPD clone
Phosphorylation of the  
  RZPD clone by kinases   
a   
Gene ORF of  
  RZPD clone
Name/biological process min:  
  S/TP
cons:  
  S/TPXK/R RXL
D1  –  K4 D3  –  K4 E  –  K2 A  –  K2 B  –  K1
NUMA1   
b    245 aa  
       C-term
Nuclear mitotic apparatus protein 1/  
       spindle apparatus organization
71 0       ± + +     
LOC201191 231 aa  
       C-term
Hypothetical protein  
       LOC201191/unknown
61 2       ± + +     
PIP5K1C 200 aa  
       C-term
Phosphatidylinositol-4-phosphate 5 kinase,   
       type I      /phosphatidylinositol signaling
72 1   ± + + +   ± 
CCNL2 136 aa  
       C-term
cyclin L2 / RNA processing 7 3 2           ± +   ± 
RASL11B 118 aa  
       C-term
RAS-like, family 11, member B/signaling? 21 0     ++ +     
SIRT2 full-length   
c    Sirtuin (silent mating type information  
       regulation 2 homologue) 2  
       (  S. cerevisiae  )/ NAD 
+  -dependent  
       histone/protein deacetylase
31 1         ++  ± 
FLJ13111 full-length Hypothetical protein FLJ13111/unknown 4 2 4       ± + +   ± 
SUPT5H   
b    120 aa  
       C-term
Suppressor of Ty 5 homologue  
       (  S. cerevisiae  )/transcription
11 1           ±         
STMN2   
b    full-length Stathmin-like 2/microtubule destabilization   
       in neuronal growth
21 1     ++ +     
LOC146909 114 aa  
       C-term
Hypothetical protein  
       LOC146909/unknown
10 1     ++ +     
EEF1G 211 aa  
       C-term
Eukaryotic translation elongation  
       factor 1     /translation
21 1       ± + +   ± 
TRIT1 99 aa  
       C-term
tRNA isopentenyltransferase 1/  
       RNA modiﬁ  cation
31 1     ++ +   ± 
LOC388799 89 aa  
       C-term
Hypothetical protein  
       LOC388799/unknown
21 0       ± + +   ± 
STUB1 full-length STIP1 homology and U-box  –  containing  
       protein 1/protein turnover
41 3     ++ +   ± 
SRRM2 98 aa  
       central
Serine/arginine repetitive matrix 2/ 
       RNA processing
30 0         +++
TALDO1 full-length Transaldolase 1/metabolism 3 1 6     ++ +     
SFRS1 243 aa  
       C-term
Splicing factor, arginine/serine-rich 1  
       (splicing factor 2, alternate splicing  
       factor)/RNA processing
41 1     ++ +     
SNAPAP full-length SNAP-associated protein/exocytosis of  
       synaptic vesicles
21 2 +   ± +
LOC339287 90 aa  
       central
Hypothetical protein  
       LOC339287/unknown
54 1 + + + + +
FLJ12949 248 aa    
         C-term
Hypothetical protein FLJ12949/unknown 4 1 3     ++         
MAP2 376 aa  
       C-term
MAP2/microtubule assembly  
       in neurogenesis
16 3 1     ++ +     
RPL14 211 aa  
       C-term
Ribosomal protein L14/translation 1 1 1       ±             
FNBP3 245 aa  
       C-term
Formin binding protein 3/splicing? 21 1       ±   ±   ±     
PRC1   
d    full-length Protein regulating cytokinesis 1/  
       cytokinesis
52 2     ++ +   ± 
FLJ13305 162 aa  
       central
Hypothetical protein FLJ13305/unknown 4 0 3     ++   ±     
ING5 full-length   
c    Inhibitor of growth family, member 5/  
       p53 pathway, replication
21 3         ++    
 
a  The kinases used are abbreviated (e.g., D1  –  K4 for cyclin D1  –  Cdk4). The substrates are phosphorylated strongly (+), weakly (  ±  ), or not at all (     ) by the respective kinase.
 
b  Previously reported Cdk substrate (  Stachora et al., 1997  ;   Gavet et al., 1998  ;   Sun and Schatten, 2006  ).
 
c  For ING5 and SIRT2, GST-tagged full-length proteins were used in the kinase assays.
 
d  Previously reported cyclin E  –  Cdk2 substrate (  Jiang et al., 1998  ).919 CYCLIN-DEDENDENT KINASE  –  DEPENDENT REGULATION OF SIRT2   •   PANDITHAGE ET AL.
was detectable in HDFs) did not change, phosphorylation in-
creased (  Fig. 2 F  ). This observation is in agreement with cyclin E  – 
Cdk2 functioning as a SIRT2 kinase (  Fig. 1 E  ), the sensitivity 
of SIRT2 phosphorylation to the cyclin E  –  Cdk2 inhibitor p27 
(  Fig. 2 A  ), the cell cycle analysis (  Fig. 2 C  ), and the sensitivity 
of SIRT2 phosphorylation to roscovitine (  Fig. 2 E  ). 
  To further strengthen the functional interaction of SIRT2 
with Cdk complexes, we analyzed whether these proteins inter-
acted physically. Coimmunoprecipitation experiments revealed 
that SIRT2 and cyclin E  –  Cdk2 interacted when coexpressed 
in HEK293 cells (  Fig. 2 G  ) and cyclin E bound to SIRT2 in 
in vitro pulldown experiments (not depicted). Furthermore, TAP-
SIRT2, TAP-SIRT2-S331A, and TAP-SIRT2-H150Y, but not 
TAP-SIRT2-S331D, interacted with endogenous cyclin E in 
HEK293 cells stably expressing the SIRT2 proteins (Fig. S2 G). 
Similarly, p35 and Cdk5 were coimmunoprecipitated with 
SIRT2 upon overexpression in HEK293 cells (  Fig. 2 H  ). Inter-
action of endogenous p35  –  Cdk5 and SIRT2 was demonstrated 
by coimmunoprecipitation from P14 mouse brain extracts (hip-
pocampus and cortex;   Fig. 2, I and J  ). Furthermore, in addition 
to previous reports showing SIRT2 expression mainly in oligo-
dendroglial cells (  Li et al., 2007  ;   Southwood et al., 2007  ), pri-
mary hippocampal neurons expressed SIRT2 throughout the 
cell body in the neurites and growth cones (Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200707126/DC1). 
Moreover, SIRT2 colocalized with p35, the regulatory subunit 
of Cdk5 (Fig. S5, A  –  D), and SIRT2 expression overlapped with 
acetylated      -tubulin in neuronal growth cones (Fig. S5, E  –  G). 
Thus p35, which has recently been shown to directly bind to 
microtubules (  Hou et al., 2007  ), colocalizes with SIRT2 and 
     -tubulin. In summary, these fi  ndings support our phosphorylation 
analysis and the notion that Cdk complexes, SIRT2, and     -tubulin 
interact functionally. 
  Phosphorylation at S331 inhibits the 
catalytic activity of SIRT2 
  Next we assessed the functional relevance of S331 phosphory-
lation. No difference in the subcellular distribution of SIRT2 
and SIRT2-S331 mutants or the stability of these proteins could 
be observed (unpublished data). Importantly, however, S331 
phosphorylation affected the catalytic activity of SIRT2. GST-
SIRT2 showed robust NAD 
+  -dependent deacetylase activity to-
ward core histones, which was blocked by nicotinamide (  Fig. 3   A    ).    
GST-SIRT2-S331A had comparable deacetylase activity when 
adjusted to protein concentrations (  Fig. 3,   A   and   B    ). In con-
trast, GST-SIRT2-S331D, a mutation that may mimic phos-
phorylation at S331, showed reduced activity (  Fig. 3,   A   and   B    ). 
All mutants with the active center His-150 (H150) changed to 
Tyr were catalytically inactive as reported previously (  Frye, 
1999 ).  These  fi  ndings suggested that phosphorylation at S331 
inhibits the enzymatic activity of SIRT2. Indeed, when GST-
SIRT2 was incubated in the presence of cyclin E  –  Cdk2 or cy-
clin A  –  Cdk2, the catalytic activity of SIRT2 was repressed (  Fig. 3, 
  C   and   D    ). These kinase-dependent effects required S331 be-
cause GST-SIRT2-S331A was not inhibited. Moreover, rosco-
vitine reversed the repressive effect (  Fig. 3   C    ). It is noteworthy 
that although p35  –  Cdk5 phosphorylated S331 (  Fig. 1   F    ), the 
Similar to cyclin E  –  Cdk2 and cyclin A  –  Cdk2 complexes, p35  –
  Cdk5 was capable of phosphorylating SIRT2 at S331 (  Fig. 1   F    ), 
suggesting that this site can be phosphorylated both in cycling 
and differentiated cells. 
  To corroborate the in vitro kinase assays, we analyzed the 
phosphorylation of SIRT2 in cells (  Fig. 2  ).    HA-tagged SIRT2 or 
SIRT2-S331A was expressed in HeLa cells and labeled with 
[ 
32  P]orthophosphate. Although SIRT2 was phosphorylated, the 
S331A mutant was only poorly labeled (  Fig. 2 A  ). Moreover, 
coexpression of the Cdk2 inhibitor p27 
KIP1   abolished  SIRT2 
phosphorylation (  Fig. 2   A    ). We also generated HEK293 cells 
stably expressing a tagged version of SIRT2 (N  –  tandem affi  nity 
purifi  cation [TAP]  –  SIRT2; Fig. S4, available at http://www.jcb
.org/cgi/content/full/jcb.200707126/DC1). The analysis of TAP-
SIRT2 isolated from exponentially growing cells by mass spec-
trometry confi  rmed SIRT2 phosphorylation at S331 (  Fig. 2   B    ). 
In support of this, a peptide that contains S331 was identifi  ed as 
phosphopeptide in a global screen (  Olsen et al., 2006  ). In addi-
tion, SIRT2 phosphorylation was high in cells blocked in S-phase 
and in prometaphase by hydroxyurea and nocodazole, respec-
tively, but low in cells blocked in metaphase by colcemide when 
analyzed by [ 
32  P]orthophosphate labeling (  Fig. 2   C    ) and mass 
spectrometry (not depicted). This correlates with active cyclin E  – 
Cdk2 and cyclin A  –  Cdk2 kinase complexes, implicating these 
kinases in SIRT2 phosphorylation. In summary, these fi  ndings 
defi  ne S331 as the major cell cycle  –  regulated Cdk-dependent 
phosphorylation site of SIRT2. 
  To expand on the observations described in the previous 
paragraph, we addressed whether endogenous SIRT2 is phos-
phorylated at Ser-331. We generated mAbs against a human 
SIRT2 Ser-331 phosphorylated peptide. The antibodies were 
screened on HA-SIRT2 and HA-SIRT2-S331A. Although mAb 
7G5 recognized both proteins, mAb 6B5 
P   detected only HA-
SIRT2 (Fig. S2 E). In support of this, the epitope was lost when 
overexpressed HA-SIRT2 was phosphatase treated, indicating 
that mAb 6B5 
P   is phosphospecifi  c (Fig. S2 F). Importantly 
the 6B5 
P   epitope was generated when bacterially expressed 
GST-SIRT2 was phosphorylated by cyclin E  –  Cdk2 (  Fig. 2 D  ). 
We then addressed whether endogenous SIRT2 was phosphory-
lated at Ser-331. Because in multiple cell lines analyzed SIRT2 
levels were low and did not allow direct analysis by Western 
blotting, we examined Ser-331 phosphorylation upon immuno-
precipitation of endogenous SIRT2. HEK293 cells were arrested 
in S-phase using hydroxyurea to enhance cyclin E  –  Cdk2  – 
dependent phosphorylation and treated the cells for the last 2 h with 
roscovitine, a Cdk2 inhibitor. In HEK293 cells, the two described 
SIRT2 isoforms, a consequence of alternative splicing (  North 
and Verdin, 2007b  ), were detected with the phosphospecifi  c 
mAb 6B5 
P   (  Fig. 2 E  ). Roscovitine treatment reduced SIRT2 
phosphorylation by at least 60% and the 6B5 
P   epitope was sen-
sitive to phosphatase treatment (  Fig. 2 E  ). Reduced phosphory-
lation correlated with the appearance of SIRT2 protein species 
with slightly increased mobility (  Fig. 2 E  , double bands). To ad-
dress cell cycle regulation, serum-starved primary human diploid 
fi  broblasts (HDFs) were stimulated with serum and entered 
S-phase by 18 h as monitored by BrdU incorporation (unpublished 
data). Although overall levels of SIRT2 (only the larger isoform JCB • VOLUME 180 • NUMBER 5 • 2008  920
  Figure 2.       SIRT2 is phosphorylated at serine 331 in cells and interacts with Cdk complexes.   (  A  ) HEK293 cells were transiently transfected with plasmids 
encoding 10   μ  g HA-SIRT2, 10   μ  g HA-SIRT2-S331A, and 5   μ  g p27, as indicated, and metabolically labeled with [ 
32  P]orthophosphate. SIRT2 was then 
immunoprecipitated via its HA-tag. The top shows an autoradiography, the bottom shows Western blots for HA-SIRT2 (mAb 3F10) and p27 
KIP1   (C-19). 
(  B  ) N-TAP-SIRT2 was puriﬁ  ed from HEK293 cells. The fragmentation spectrum of parent ion m/z 1144.5163, 2 + (mass accuracy, 2.8 ppm) is shown. 
Mascot searches against the Uniprot database identiﬁ  ed that this peptide unambiguously phosphorylated at position Ser-331 with a Mascot ion score of 
68 (Expectance value, 1.9*E-4). The phosphopeptide was sequenced eight times from two unique overlapping peptide sequences because of the pres-
ence of miscleaved tryptic sites. The y-ion fragmentation ladder starting from the C terminus is shown in red. The phosphorylation site was mapped by 
the detection of the y 
+    3   fragment ion in the linear ion trap at m/z 411.3, which corresponds to the sequence pSPK. (  C  ) HEK293 cells were transiently 
transfected with a plasmid encoding 10   μ  g HA-SIRT2 and treated with 200   μ  M hydroxyurea, 400 ng/ml nocodazole, or 200 ng/ml colcemide for 20 h 
and then metabolically labeled with [ 
32  P]orthophosphate. The SIRT2 analysis was performed as described in   A  . White lines indicate that intervening lanes 
have been spliced out. (D) Bacterially expressed and puriﬁ  ed GST-SIRT2 or GST was phosphorylated by recombinant cyclin E  –  Cdk2 in the presence or 
absence of ATP as indicated. Half of the reactions were analyzed by Coomassie blue (CB) staining, the other half were subjected to Western blot analysis 
using the mAb 6B5 
P   that is speciﬁ  c for Ser-331 phosphorylated SIRT2. (E) HEK293 cells were treated as indicated with hydroxyurea (HU) for 16 h and 
with roscovitine (Rosc) for the last 2 h. SIRT2 was immunoprecipitated using the polyclonal serum 748 from RIPA lysates of 6   ×   10 
6   cells. The immuno-
precipitated proteins were phosphatase or mock treated and the proteins were analyzed by Western blotting with the indicated mAbs. Equal aliquots of the 
lysates were taken before immunoprecipitation and      -tubulin expression was determined. (F) Primary HDFs were serum starved and then treated with 10% 
serum for the indicated times. Parallel samples were analyzed for BrdU incorporation, indicating that the cells started to enter S-phase 18 h after serum 
addition. SIRT2 was immunoprecipitated from lysates of roughly 4   ×   10 
6   cells per sample and detected with the indicated mAbs. (G) HEK293 cells were 
cotransfected with Flag-SIRT2, cyclin E, and Cdk2 construct. Their expression was visualized in total cell lysates by Western blotting (right). Flag-SIRT2 was 
immunoprecipitated and the association of coexpressed cyclin E and Cdk2 analyzed by Western blotting (left). (H) The experimental setup and analysis 
was as in D. Constructs expressing Flag-SIRT2, HA-Cdk5, and myc-p35 were used. (I) Low-stringency lysates of P14 mouse brain were generated and Cdk5 
was immunoprecipitated. Coimmunoprecipitated SIRT2 was visualized by Western blotting. (J) The experiment was performed as in F. SIRT2 was immuno-
precipitated with two different polyclonal antisera (T749 and T809). For a control, p35 and Cdk5 were immunoprecipitated. Cdk5 coimmunoprecipitated 
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NAD 
+  -dependent manner (  Fig. 3 G  ). Finally, we coexpressed 
SIRT2 with cyclin E  –  Cdk2 or p35  –  Cdk5 and measured HDAC 
activity of immunoprecipitated SIRT2. Both kinases inhibited, 
whereas p27 
KIP1   slightly stimulated, the catalytic activity of SIRT2 
(  Fig. 3   H    ). Collectively, our data demonstrate that phosphory-
lation at S331 represses the enzymatic activity of SIRT2. 
  SIRT2 regulates cell adhesion and cell 
migration 
  It had been suggested that SIRT2 affects passage through mito-
sis, possibly as a consequence of altered     -tubulin  acetylation 
(  Dryden et al., 2003  ;   North et al., 2003  ). Therefore, we tested 
whether SIRT2 and mutants altered the cell cycle in HeLa and 
HEK293 cells. No systematic effects on cell cycle distribution 
and proliferation could be measured (Fig. S4). However, we 
poor catalytic activity and the instability of this commercially 
available complex did not allow us to directly test its in vitro ef-
fects on SIRT2 catalytic activity. However, because p35  –  Cdk5 
also phosphorylates S331, it is highly likely that the deacetylase 
activity of SIRT2 would be inhibited. 
  Finally, we addressed whether SIRT2 expressed in mam-
malian cells was catalytically active. HA-SIRT2 and mutants were 
expressed in HEK293 cells, immunoprecipitated, and assayed 
for HDAC activity (  Fig. 3,   E   and   F    ). As for the bacterially ex-
pressed proteins, SIRT2 had comparable activities to SIRT2-
S331A, whereas the phospho-mimicking mutants were less 
  active when compared with input. In addition, nicotinamide in-
hibited the catalytic activity and SIRT2-H150Y was inactive 
(  Fig. 3,   E   and   F    ). Furthermore, SIRT2 and SIRT2-S331A, but 
not SIRT2-H150Y, deacetylated      -tubulin in brain extracts in a 
  Figure 3.       Phosphorylation at serine 331 inhibits the catalytic activity of SIRT2.   (  A  ) The indicated bacterially expressed and puriﬁ  ed GST-SIRT2 fusion pro-
teins were used in HDAC assays. The release of radioactivity from  
3  H-acetylated core histones was determined. The activity of GST-SIRT2 was set as 100%. 
Nicotinamide was used at 10 mM. Mean values and SD of three experiments are shown. (  B  ) Coomassie blue staining of GST-SIRT2 fusion proteins used in   A  . 
(  C   and   D  ) HDAC assays were performed as in   A  . Before this, the GST-SIRT2 proteins were phosphorylated with recombinant cyclin A  –  Cdk2 and cyclin E  – 
Cdk2 complexes. Nicotinamide and roscovitine were used at 10 mM and 25   μ  M, respectively. Mean values and SD of three experiments are shown. 
(  E  ) HEK293 cells were transiently transfected with 10   μ  g of plasmids encoding the indicated SIRT2 proteins. The HA-tagged proteins were immuno-
precipitated and the associated HDAC activity was determined as described in   A  . The assays were performed in the presence of 20   μ  M trichostatin A to 
inhibit class I or II HDACs that were potentially associated with the immunoprecipitates. Nicotinamide was used at 10 mM. A typical experiment is shown. 
(  F  ) Aliquots of the immunoprecipitates (10%) used in   E   were analyzed by Western blotting using mAb 3F10, which is speciﬁ  c for the HA-tag. (  G  ) SIRT2 and 
SIRT2 mutants were expressed in HEK293 cells, immunoprecipitated, and assayed for      -tubulin deacetylase activity using brain extracts as a source for 
substrate. Acetylation of      -tubulin was determined by Western blotting. (H) The experiments were performed as described in   E  . The relative activities were 
standardized to SIRT2 protein expression. Mean values and SD of an experiment performed in triplicate are shown.     JCB • VOLUME 180 • NUMBER 5 • 2008  922
a lesser extent, by SIRT2 (  Fig. 5   D    ; and not depicted). In agree-
ment with SIRT2 being a novel Cdk5 effector, SIRT2-mediated, 
but not SIRT2-S331A-mediated, neurite outgrowth inhibition 
was rescued at least partially by p35  –  Cdk5 (  Fig. 5 E  ). 
  The overexpression fi  ndings were complemented by KD 
of SIRT2, which resulted in a signifi  cant increase of neurite 
length (  Fig. 5, F and G  ). Notably, the number of neurons with 
very long neurites (  >  150   μ  m) was increased almost threefold 
in SIRT2 KD cells (  Fig. 5   G    ). Finally, we also observed an in-
crease in total neurite number (on average 25%) per neuron upon 
SIRT2 KD (unpublished data), further stressing SIRT2  ’  s inhibi-
tory role in neurite outgrowth. To address potential off-target 
effects, we used a second mouse-specifi  c   SIRT2   siRNA that 
also increased neurite length (unpublished data), whereas a 
human-specifi  c   SIRT2   siRNA was indistinguishable from siLUC. 
In summary, these fi  ndings demonstrate a decisive role of SIRT2 
in neurite outgrowth of primary neurons, which is in agreement 
with its role in oligodendroglial arborization (  Li et al., 2007  ). 
  SIRT2 impairs cytoskeletal growth cone 
dynamics stimulated by repulsive axon 
guidance cues 
  A well-established paradigm to study axon guidance in tissue 
culture is the so-called growth cone collapse assay. Members of 
the ephrin-A family trigger growth cone repulsion through 
stimulating EphA receptor tyrosine kinases, thereby preventing 
growth cones from turning into aberrant target areas of the brain 
(  Knoll and Drescher, 2002  ;   Pasquale, 2005  ). Cdk5 is a key me-
diator of EphA receptor-mediated repulsion (  Cheng et al., 2003  ; 
  Fu et al., 2007  ). Consequently, we explored the role of SIRT2 in 
growth cone collapse. Hippocampal neurons revealed typical 
well-elaborated growth cones with fi  nger-like fi  lopodial and 
veil-like lamellipodial structures in response to Fc control pro-
teins (  Fig.   6 A    ).    In contrast, ephrin-A5-Fc induced a complete 
breakdown of the growth cone F-actin cytoskeleton within 
30 min, leaving the neurites with a retracted neurite shaft (  Fig.   6, 
A   and B  ;   Knoll et al., 2006  ). Importantly the growth cones of neu-
rons expressing SIRT2 or SIRT2-S331A, but not SIRT2-S331
A-H150Y, SIRT2-S331E, or SIRT2-S331D, were resistant to 
ephrin-A5-Fc – induced  collapse  ( Fig.  6, A – C ;  and  not  depicted). 
Thus, ephrin-A5-Fc collapsed 60  –  70% of the growth cones, an 
effect that was reduced to 30  –  40% by SIRT2 and SIRT2-S331A 
(  Fig. 6 B  ). In summary, the reduction in growth cone collapse 
by SIRT2 and SIRT2-S331A was     50 and 75%, respectively 
(  Fig. 6 C  ). Similar to the reduced      -tubulin acetylation in the 
entire neuron (  Fig. 5 D  ), we determined a reduction of acety-
lated      -tubulin as compared with the control by 40 and 25% in 
response to SIRT2-S331A and SIRT2, respectively, in growth 
cones (not depicted). 
  F-actin staining was reduced 2.5-fold upon ephrin-A5-Fc 
treatment (  Fig. 6 D  ). This could not be further enhanced by co-
expressing p35  –  Cdk5, although the expression of this kinase 
complex slightly reduced F-actin staining in the absence of 
ephrin-A5-Fc. Importantly, and in accordance with the morpho-
logical assessment of growth cone collapse (  Fig. 6, A  –  C  ), the 
expression of SIRT2 and SIRT2-S331A blocked the ephrin-A5-Fc  – 
induced growth cone collapse as revealed by F-actin staining. 
  noticed cell detachment upon induction of SIRT2-S331A in 
HEK293 cells and analyzed this further. SIRT2 and SIRT2-
S331A resulted in a 2.5- and 4-fold increase, respectively, of 
detached cells (  Fig. 4,   A   and   B    ).    Importantly, the catalytically 
inactive mutant SIRT2-H150Y and the phospho-mimicking 
mutant SIRT2-S331D with reduced catalytic activity had no ef-
fect (  Fig. 4   B    ). SIRT2-mediated inhibition of cell adhesion 
  coincided with a reduced     -tubulin  acetylation  ( Fig.  4   C   ) .  Con-
versely, knockdown (KD) of SIRT2 using a siRNA that targets 
both human and mouse   SIRT2   increased substratum adhesion of 
transfected cells and resulted in an increase of     -tubulin  acety-
lation ( Fig. 4, D and E ). Cyclin E – Cdk2 or p35 – Cdk5 effi  ciently 
inhibited SIRT2-induced cell detachment (  Fig. 4   D    ) but had no 
effect on SIRT2-S331A (  Fig. 4   F    ). To test whether SIRT2 also 
affected cell adhesion of primary cells, we expressed SIRT2 and 
mutants in mouse embryonic fi  broblasts (MEFs). Similar to the 
observation in HEK293 cells, SIRT2 and SIRT2-S331A inhib-
ited attachment of MEF cells to laminin-coated coverslips in com-
parison with the catalytically inactive SIRT2-H150Y (  Fig. 4 G  ). 
In addition to cell adhesion, SIRT2 function was explored in 
migration of MEF cells (  Fig. 4 H  ). A mechanical scratch was 
applied to MEF monolayers transiently expressing SIRT2 or 
SIRT2 mutants and reinvasion of the cleared area by cells was 
monitored. In line with the results obtained in cell adhesion 
( Fig.  4,  A – F ),  SIRT2  slightly,  and  SIRT2-S331A  signifi  cantly, 
blocked migration of MEFs (  Fig. 4 H  ). These fi  ndings suggest 
that altering the SIRT2 activity in cells affects the interaction of 
cells with the substratum, possibly by altering the stability of 
microtubules because of differential acetylation. 
  SIRT2 overexpression inhibits neurite 
outgrowth 
  The intimate link between p35  –  Cdk5 and SIRT2, as shown by 
the ability of Cdk5 to phosphorylate SIRT2 (  Fig. 1 F  ), which is 
shown by coimmunoprecipitation studies (  Fig. 2, I and J  ) and 
deacetylation assays (  Fig. 3 H  ), suggests that SIRT2 functions 
as a novel downstream effector of Cdk5. Microtubules possess 
pivotal functions in regulating multiple aspects of neuronal mo-
tility, including migration, neurite outgrowth, and growth cone 
turning (  Dent and Gertler, 2003  ;   Gordon-Weeks, 2004  ). Cdk5 
has been implicated in all these processes (  Dhavan and Tsai, 
2001 ;   Nikolic,  2004 ).  Therefore,  we  fi  rst assessed the role of 
SIRT2 in neurite formation and protrusion (  Fig. 5  ).    Primary 
mouse hippocampal neurons were coelectroporated with SIRT2 
and GFP-expressing plasmids and cultured for 2 d on laminin to 
promote neurite outgrowth. The cells were then stained for acet-
ylated      -tubulin and the neurite length of GFP-positive cells 
was determined (  Fig. 5  ). SIRT2 and, more profoundly, SIRT2-
S331A reduced neurite length, whereas SIRT2-H150Y, SIRT2-
H150Y-S331A, SIRT2-S331E, and SIRT2-S331D had no effect 
(  Fig. 5,   A   and B  ; and not depicted). Of note, quantifi  cation of 
the neurite length (  Fig. 5   B    ) underestimated the consequence of 
SIRT2-S331A expression because in more than half of the cells, 
neurite formation was completely abolished, resulting in a 
rounded-up phenotype (  Fig. 5,   A   and   C    ). This was not observed 
for SIRT2, which can be phosphorylated and thereby inhibited. 
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ephrin-A5-Fc a strong effect on growth cones was observed 
(  Fig. 6 E  ). Growth cones of siSIRT2-treated neurons protruded 
signifi  cantly less fi  lopodia in comparison to siLUC control  –
  treated cells. Thus, in cells in which SIRT2 was knocked down, 
a collapsed morphology was observed already in the absence of 
ephrin-A5-Fc. In support of this, the KD of SIRT2 also resulted 
Importantly, the effect of SIRT2, but not of SIRT2-S331A, was 
reverted by p35  –  Cdk5 (  Fig. 6 D  ). Because SIRT2 and SIRT2-
S331A stabilized growth cones upon ephrin-A5 treatment, we 
investigated the effect of SIRT2 KD on growth cones, expecting 
that reduced SIRT2 expression would sensitize these structures 
to ephrin-A5-Fc treatment. However, already in the absence of 
  Figure 4.       SIRT2 affects cell attachment and mobility.   (  A  ) HEK293 cells were transiently transfected with plasmids encoding 0.5   μ  g EGFP  –       -tubulin, 20   μ  g 
HA-SIRT2, or 20   μ  g HA-SIRT2-S331A and 20   μ  g of a siRNA-expressing plasmid (siSIRT2). The cells from equal aliquots of the culture supernatants were 
analyzed by phase contrast and ﬂ  uorescence microscopy. (  B  ) The percentage of transfected cells (EGFP positive) of the adherent and the detached cell 
population was determined as in A. Displayed is the percentage of transfected cells that were detached. Mean values and SD of three experiments are 
shown. (  C  ) HEK293 cells were transfected with plasmids expressing the indicated SIRT2 proteins and a plasmid coding for CD4. Transfected cells were 
selected using magnetic beads coated with CD4-speciﬁ  c antibodies. Equal amounts of cell lysates were analyzed by Western blotting for      -tubulin acety-
lation. (  D  ) HEK293 cells were transiently transfected as in   A,   but with the following amounts of plasmids: 20   μ  g siSIRT2, 20   μ  g siLUC, 10   μ  g HA-SIRT2, 
5   μ  g Cdk5, 0.5   μ  g cyclin E, 0.5   μ  g Cdk2, and 0.5   μ  g EGFP  –       -tubulin. The analysis was performed as described in   B  . Mean values of two experiments 
are shown. (E) HEK293 cells were transiently transfected with plasmids expressing siSIRT2, siLUC, and CD4.      -Tubulin acetylation was analyzed in lysates 
of CD4-positive cells. The levels of SIRT2 were determined after immunoprecipitation (polyclonal serum 749) and Western blot analysis (mAb 7G5). (  F  ) The 
experiment was performed as described in   D  . Mean values of two experiments are shown. (G) MEFs were transfected with plasmids expressing the indi-
cated SIRT2-GFP fusion proteins. Trypsinized cells were replated on laminin-coated coverslips for 30 min. Nonadherent and adherent cells were counted. 
Mean values and SD of three independent experiments are displayed. (  H  ) MEFs were transfected with the indicated expression plasmids. Conﬂ  uent cell 
layers were scratched and the ratio of migrating versus nonmigrating transfected cells was determined. Mean values and SD of three to ﬁ  ve experiments 
are shown. *, P   <   0.05; **, P   <   0.01; ***, P   <   0.001.     JCB • VOLUME 180 • NUMBER 5 • 2008  924
Cdks phosphorylate Ser-331 within a Cdk consensus sequence 
of SIRT2 that is conserved in several Sirtuin family mem-
bers (  Figs. 1, 2  , and S2). Mechanistically, phosphorylation at 
this site represses the enzymatic activity of SIRT2 (  Fig. 3  ), 
re presenting  the  fi  rst account of a posttranslational modifi  cation 
linked to SIRT2 enzymatic activity. Recently, the comparable 
site in an alternatively spliced version of SIRT2 was identifi  ed 
as cyclin B  –  Cdk1 substrate but no function was assigned to this 
modifi  cation (  North and Verdin, 2007b  ). This may be because 
of the relative low activity of cyclin B  –  Cdk1 toward SIRT2 in 
comparision to the Cdk2 complexes as observed both in vitro 
and in cells (  Figs. 1 and 2  ). 
  To date, two SIRT2 substrates,      -tubulin and histone H4, 
have been described (  Dryden et al., 2003  ;   North et al., 2003  ; 
in an     25% reduction in F-actin content in growth cones in the 
absence of ephrin-A5 (  n   = 100 growth cones each; unpublished 
data), which is consistent with morphological alterations ob-
served in these growth cones (  Fig. 6 E  ). In summary, these fi  nd-
ings suggest strongly that the EphA-stimulated growth cone 
collapse is mediated at least in part by the phosphorylation and 
thereby repression of the deacetylase activity of SIRT2. 
  Discussion 
  Sirtuins have received considerable attention because of their role 
in aging, neuroprotection, and gene transcription (  Haigis and 
Guarente, 2006  ;   Michan and Sinclair, 2007  ). We identifi  ed SIRT2 
in a phosphorylation screen with recombinant cyclin E  –  Cdk2. 
  Figure 5.       SIRT2 modulates neurite outgrowth 
of hippocampal neurons.   (  A  ) Hippocampal 
neurons were coelectroporated with constructs 
expressing the indicated SIRT2 proteins and 
a GFP vector and cultivated for 2 d in vitro, 
followed by staining for acetylated      -tubulin. 
Arrowheads identify some of the GFP-express-
ing cells. Bars, 50   μ  m. (  B  ) Quantiﬁ  cation of ex-
periments exempliﬁ  ed in   A  . The neurite length 
was determined in response to the expressed 
proteins indicated. The neurite length of neu-
rons electroporated with the parental vector 
was set to 100%. Only neurons with measur-
able neurites were taken into account. Relative 
neurite length is expressed in percentage of 
control (set to 100%). (  C  ) Neurons without any 
detectable neurite growth were determined 
in response to the indicated SIRT2 proteins. 
(  D  ) The level of acetyl-     -tubulin in SIRT2-S331A  –
  expressing and control electroporated neurons 
was compared. A total of 60 neurons (20 in 
each of three independent experiments) were 
captured and acetylated      -tubulin levels mea-
sured using AxioVision software. The values 
from control cells were set to 100%. (  E  ) Neu-
rite length was measured, as in A, in response 
to coexpressed p35  –  Cdk5. (F) Neurons were 
coelectroporated with vectors expressing GFP 
and the indicated siRNAs. The neurite length of 
neurons electroporated with siLUC was set to 
100%. Relative neurite length is expressed in per-
centage of control (set to 100%). ( G  ) The neurites 
were classiﬁ  ed into four length groups, from 
very short (0  –  50   μ  m) to very long (  >  150   μ  m). 
The percentage of neurons within each group is 
displayed. Error bars represent SD. **, P  <   0.01; 
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lation is associated with stable microtubules (  Dent and Gertler, 
2003 ;   Westermann and Weber, 2003  ). We used multiple assays 
to investigate a role for SIRT2 in cell motility, including adhe-
sion, migration, neurite outgrowth, and growth cone collapse 
(  Figs. 4  –  6  ). All the aforementioned processes share signaling 
through focal contacts leading to attachment/detachment of 
cells from their substratum. Because microtubules and focal ad-
hesions show extensive crosstalk (  Ezratty et al., 2005  ), it is pos-
sible that      -tubulin deacetylation also affects the activities of 
focal adhesions. An increase in microtubule dynamics because 
of a reduction in      -tubulin acetylation might modulate focal 
adhesion turnover and thereby control cell motility. In neu-
rons, an important cross talk between dynamic microtubules 
and actin fi  laments takes place at the central/peripheral growth 
cone interface to regulate target-directed advancement of the 
growth cone (  Dent and Gertler, 2003  ). Microtubules have been 
shown to be crucially involved in both neurite outgrowth and 
chemotactic sensing of guidance cues in the surrounding of 
navigating growth cones (  Gordon-Weeks, 2004  ). In neurons, 
acetylated microtubules are polarized toward the starting point 
  Vaquero et al., 2006  ). SIRT2 deacetylates histone H4 at Lys-16 
during G  2  /M, during which a subfraction of SIRT2 associates 
with chromatin. Deacetylation of H4K16 was suggested to be 
relevant for effi  cient chromatin condensation (  Vaquero et al., 
2006  ). The lack of SIRT2 results in a decrease in S-phase and 
increase in G  1  -phase in MEFs without apparent effect on mitosis. 
In contrast, in human tumor cells overexpression of SIRT2 de-
layed exit from mitosis, probably because of altered     -tubulin 
acetylation (  Dryden et al., 2003  ). Recently, SIRT2 was shown 
to inhibit mitotic slippage in cells treated with mitotic spindle 
drugs (  Inoue et al., 2007  ;   North and Verdin, 2007b  ), suggesting 
a role in genetic stability. In agreement with this, SIRT2 is down-
regulated in certain tumors (  Hiratsuka et al., 2003  ;   Matsushita 
et al., 2005  ;   Voelter-Mahlknecht et al., 2005  ;   Inoue et al., 2007  ). 
Our own analysis did not reveal any reproducible effects on 
mitosis in response to SIRT2, SIRT2 mutants, or KD of SIRT2 
in tumor cell lines in the absence of stress (Fig. S4). 
  We provide evidence that SIRT2 impairs cell motility, at 
least in part by infl  uencing microtubule dynamics, which is a 
function regulated by Cdk phosphorylation.     -Tubulin  acety-
  Figure 6.       SIRT2 overexpression impairs 
ephrin-A  –  mediated growth cone collapse.   
(  A)   Hippocampal neurons were coelectroporated 
with constructs expressing the indicated SIRT2 
proteins and a GFP vector. The cells were culti-
vated on laminin for 2 d and then treated with 
1   μ  g/ml ephrin-A5-Fc or Fc for 30 min and 
subsequently stained for F-actin. (B) The per-
centage of collapsed growth cones was quanti-
ﬁ  ed by morphological criteria. (  C  ) Summary of 
the overall change in the growth cone collapse 
rate. The percentage of growth cone collapse 
in response to ephrin-A5-Fc was subtracted 
from the response to Fc alone. (D) Neurons 
were coelectroporated with constructs express-
ing the indicated proteins. The cells were then 
stained for F-actin and the ﬂ  uorescence intensity 
of individual growth cones was determined. 
Untreated growth cones contain high F-actin 
levels, which are decreased upon ephrin-A5 
treatment. The mean values and SD of 50 or 
more individual growth cones/conditions are 
displayed. (E) Neurons were coelectroporated 
with constructs expressing siSIRT2 or siLUC. 
Growth cones were stained for      -tubulin (left, 
red) and F-actin (left, green). Quantiﬁ  cation of 
the mean number of ﬁ  lopodia/growth  cones 
after siSIRT2 or siLUC treatment is shown on 
the right. (F) Model of SIRT2 function and regu-
lation by Cdk complexes. For details, see Dis-
cussion. Error bars represent SD. **, P   <   0.01; 
***, P   <   0.001.     JCB • VOLUME 180 • NUMBER 5 • 2008  926
different aspects of tumor cell biology, including elevated cell 
migration and cell cycle progression. 
  Materials and methods 
  Cells, transfections, and assays 
  HEK293, MEF, and HeLa cells were cultured in DME supplemented with 
penicillin/streptomycin and 10% FCS. Transient transfection assays were 
performed as described previously (  Luscher-Firzlaff et al., 2006  ). HEK293 
Flp-In T-REx 293 cells (Invitrogen) were stably transfected with pcDNA5/
FRT/TO/N-TAP-SIRT2 or -SIRT2-S331A by coexpressing the Flp recombinase. 
Cell lysates of HDFs were obtained from J. Baron and U. Linzen (Rheinisch-
Westf  ä  lische Technische Hochschule Aachen University, Aachen, Ger-
many). Preparation and electroporation of primary hippocampal cultures 
were performed as described previously (  Knoll et al., 2006  ). In brief, 
hippocampi of P1-P3 mice were incubated in trypsin-EDTA at 37  °  C for 
10 min, followed by washing in HBSS and resuspending in prewarmed 
DME/10% horse serum (HS). The tissue was triturated using ﬂ  ame-polished 
Pasteur pipettes and spun down for 5 min at 600 rpm and the pellet was 
reconstituted in DME/HS. After counting, the cells were pelleted and then 
resuspended in mouse neuron Nucleofector solution (Amaxa) as recom-
mended by the manufacturer. A total of 3   μ  g DNA (2.25   μ  g of the desired 
construct and 0.75   μ  g of permuted EGFP) was used for electroporation per 
sample. Cultures were plated in neurobasal medium supplemented with 
B27 supplement (Invitrogen) for 2 d in vitro. The signiﬁ  cance of experimen-
tal results was determined by   t   test (two sided), with one asterisk indicating 
P   <   0.05, two asterisks P   <   0.01, and three asterisks P   <   0.001. 
  To determine the detached cells, transiently transfected HEK293 
cells were identiﬁ  ed by analyzing EGFP-positive cells. 2 d after transfec-
tion, the number of transfected detached and transfected adherent cells 
was counted, and from this the rate of detachment was determined. 
  For cell migration, 10 
5   MEFs were plated in one well of a 24-well 
plate, followed by transfection with Lipofectamine for 6  –  8 h in Optimem 
(0.6   μ  g SIRT2 construct plus 0.2   μ  g GFP/well). The next day, a scratch was 
applied and cell migration into the cleared area was monitored 12 and 
24 h afterward. The number of GFP-positive cells in and outside the scratch 
was determined along with bright ﬁ  eld recording. 
  To determine the effect of SIRT2 on      -tubulin acetylation in cells, 
HEK293 cells were cotransfected with plasmids expressing SIRT2 and the 
human CD4 antigen with a truncated cytoplasmic domain (pMACS4.1; 
Miltenyi Biotec) at a ratio of 3:1. CD4-positive cells were selected using 
magnetic beads coated with antibody speciﬁ  c for CD4 according to the 
manufacturer  ’  s instruction (Dynabeads CD4; Invitrogen). Selected cells 
were lysed in RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% 
NP-40, 1% deoxycholate, 0.1% SDS, 7   μ  g/ml aprotinin, and 20 mM 
     -glycerophosphate), and      -tubulin, acetylated      -tubulin, and SIRT2 were 
detected by immunoblotting. 
  Plasmid constructs 
  All SIRT2 constructs and Cdk5 were generated by recombining the PCR-
ampliﬁ  ed ORF into pDonR201 of the Gateway cloning system (Invitrogen) 
by virtue of attB1 and attB2-mediated BP-clonase reaction. A subsequent 
LR-recombination reaction with Gateway-compatible pGex4T2 and pE-
VRF0-HA resulted in GST- and HA-tagged expression constructs. Site-
directed mutagenesis was performed using the quick change protocol 
(Stratagene) to generate the S331A, S331D, S331E, H150Y, and S331A-
H150Y mutants. All constructs were veriﬁ  ed by DNA sequencing. pCMV-
EGFP-tubulin was cloned by standard procedures. For constructs expressing 
siRNA speciﬁ  c for SIRT2, the sequence 5     -GATCCCCGTT CACAGCCTAG 
AATATATTCA AGAGATATAT TCTAGGCTGT GAACTTTTTG GAAA-3     was 
cloned into pSUPER (provided by R. Bernards, Netherlands Cancer Insti-
tute, Amsterdam, Netherlands). This sequence is identical for both human 
and mouse. For a mouse-speciﬁ  c siSIRT2, the sequence 5     -GATCCCCCTT 
CCACCGCGCT TCTTCTTTCA AGAGAAGAAG AAGCGCGGTG G  A  A  G-
TTTTTG GAAA-3      was used. Additional constructs have been described 
previously (  Rottmann et al., 2005  ;   Luscher-Firzlaff et al., 2006  ). 
  Preparation of active cyclin  –  Cdk complexes 
  Expression and puriﬁ  cation of human cyclin D, A, and E in complexes with 
Cdk2 and 4 from insect cells coinfected with recombinant baculoviruses 
were performed as previously described (  Sarcevic et al., 1997  ). Baculo-
viruses expressing cyclin B and Cdk1 were provided by D. Morgan (Univer-
sity of California, San Francisco, San Francisco, CA). The activities of 
Cdk4 or Cdk2 and 1 complexes were measured using pRb 
778-928   or histone 
of the fi  rst nerve fi  ber protrusion (  de Anda et al., 2005  ). It is 
possible that deacetylation of      -tubulin might block directed 
protrusion of a neurite, which would be consistent with our 
observation that SIRT2 inhibits neurite outgrowth (  Fig. 5  ). 
The most dramatic effects were observed with nonphosphory-
latable SIRT2-S331A. 
  Cdk5 is essential for neurite outgrowth during neuronal 
differentiation (  Nikolic et al., 1996  ) and is required, together 
with its regulatory subunits, for the cytoarchitecture of the cen-
tral nervous system (  Dhavan and Tsai, 2001  ). Cdk5 has been 
implicated in the regulation of the actin and microtubule net-
work by phosphorylating several proteins associated with 
these cytoskeletal components, including p27 
KIP1  , PAK1, FAK, 
doublecortin, and microtubule-associated proteins (MAPs) like 
MAP1B and tau (  Nikolic et al., 1998  ;   Xie et al., 2003  ;   Drewes, 
2004  ;   Tanaka et al., 2004  ;   Kawauchi et al., 2006  ). Of interest is 
the analysis of p27 
KIP1  , which is a substrate of both Cdk2 and 5. 
However, different sites are phosphorylated. Cdk2 modifi  es 
Thr-187, stimulating degradation, and Cdk5 phosphorylates 
Ser-10, enhancing stability in a cell type  –  specifi  c manner. 
The latter is observed in neurons and is necessary for neuronal 
migration (  Kawauchi et al., 2006  ). In other situations, the precise 
function of Cdk5-dependent phosphorylation may be less well 
understood; however, in general, stabilization of microtubules 
is observed. It is noteworthy that Cdk5 was previously shown to 
be an important downstream effector of the EphA receptor 
(  Cheng et al., 2003  ;   Fu et al., 2007  ). Hence, the EphA-Cdk5-
SIRT2 signaling cascade might ensure full growth cone collapse. 
In this respect, Cdk phosphorylation and thereby inactivation of 
SIRT2-mediated      -tubulin deacetylation might contribute to-
ward maintaining stable microtubules. Besides     -tubulin,  we 
cannot rule out additional SIRT2 substrates that might contrib-
ute to the cell motility phenotypes reported here. Indeed, the 
 recent  identifi  cation of several cytoplasmic proteins, which 
are acetylated (  Kim et al., 2006  ), suggests that SIRT2 and other 
cytoplasmic deacetylases will have additional substrates that 
will be important to defi  ne in the future. 
  Cyclin E  –  Cdk2 is implicated in the development of hu-
man tumors (  Musgrove, 2006  ). The identifi  cation of SIRT2 as a 
novel substrate and its role in cell motility suggests that cyclin E  – 
Cdk2 can regulate distinct aspects of the cytoskeleton. This 
raises the question of how these kinases get access to cytoskele-
tal components because both cyclin E – Cdk2 and cyclin A – Cdk2 
are predominantly nuclear. A recent study demonstrates that 
both kinase complexes shuttle between the nuclear and cytoplas-
mic compartments, enabling access to cytoplasmic substrates 
(  Jackman et al., 2002  ). In addition to its interaction with SIRT2 
(  Fig. 2  ), a role of Cdk2 in microtubule dynamics is supported 
by the identifi  cation of stathmin-like 2 (STMN2 or SCG10; 
  Grenningloh et al., 2004  ;   Morii et al., 2006  ) and MAP2 (  Dehmelt 
and Halpain, 2004  ) as potential substrates (  Table I  ). STMN2 
and MAP2 infl  uence microtubule stability, are regulated by 
Cdk5, and affect neurite outgrowth (  Dent and Gertler, 2003  ). 
Collectively, these fi  ndings suggest that cyclin E  –  Cdk2, acti-
vated by proliferation signals or oncogenic mutations, regulates 
microtubule dynamics by phosphorylating several substrates as-
sociated with microtubules (  Fig. 6   F    ). This could be relevant for 927 CYCLIN-DEDENDENT KINASE  –  DEPENDENT REGULATION OF SIRT2   •   PANDITHAGE ET AL.
tial search criteria were applied: 20 parts per million (ppm) for the paren-
tal peptide and 0.5 D for fragmentation spectra and a ﬁ  xed carbamidomethyl 
modiﬁ  cation for cysteines. Oxidation of methionine, deamidation (gluta-
mine and asparagine), and phosphorylation (serine, threonine, and tyro-
sine) were searched as variable modiﬁ   cations. Parent ion masses were 
internally calibrated by MSQuant (http://msquant.sourceforge.net) to ob-
tain accurate masses better than 5 ppm. Fragmentation spectra of phospho-
peptides were manually veriﬁ  ed. 
  Antibodies, immunoprecipitation, and Western blotting 
  The polyclonal anti-SIRT2 T749 and T809 antisera were raised against a 
bacterially expressed GST-SIRT2 fusion protein (Eurogentec). The following 
antibodies are commercially available from the indicated sources: Cdk2 
pAb H-298, Cdk5 pAb C-8, cyclin E pAb M-20, GFP pAb (FL), p27 pAb 
C-19, p35 pAb C-19, and SIRT2 mAb A-5 (Santa Cruz Biotechnology, 
Inc.); HA-tag mAb 3F10 (Roche); and acetyl-     -tubulin mAb 6–11-B-1 and 
     -tubulin mAb B-5-1-2 (Sigma Aldrich). Low stringency immunoprecipita-
tions and coimmunoprecipitations and Western blotting were done as 
described previously (  Vervoorts et al., 2003  ). mAbs speciﬁ  c for Ser-331 
phosphorylated human SIRT2 were generated against the synthetic peptide 
  NPSTSAS(  phosphorylated  )PKKSPPPAKDEARTTEREKPQ   in Lou/C rats. 
  HDAC assay 
  Immunoprecipitated material was washed in SIRT2 deacetylase buffer 
(50 mM Hepes, pH 7.5, 10 mM MgCl  2  , 10 mM NaF, 10 mM      -glycerophos-
phate, 0.2 mM DTT, and 25   μ  M ATP), which is identical to the kinase buffer. 
Both immunoprecipitated material and recombinant SIRT2 were resuspended 
in 50   μ  l SIRT2 deacetylase buffer containing 1 mM NAD 
+   (Sigma-Aldrich) 
and  
3  H-acetylated chicken reticulocyte core histone (    7.5   μ  g correspond-
ing to 12,000 cpm per reaction; obtained from P. Loidl, Innsbruck Medical 
University, Innsbruck, Austria). The reactions were performed in the pres-
ence of 20   μ  M trichostatin A to block potentially copuriﬁ  ed HDAC activities 
at 37  °  C for 60 min. The acetyl-group of   O  -acetyl-ADP-ribose was hydro-
lysed by adding 15   μ  l of 1 N NaOH at room temperature for 20 min, 
followed by adding 185   μ  l of 0.1 M HCl and 0.16 M acetic acid. 
Released [ 
3  H]acetate was extracted in 750   μ  l ethyl acetate and counted 
(  Borra et al., 2004  ). Deacetylation of brain-derived      -tubulin was performed 
with 25   μ  g of P3-P4 mouse forebrain lysate essentially as described previ-
ously (  North et al., 2003  ). 
  Immunocytochemistry 
  Cultures were ﬁ  xed with PBS containing 4% paraformaldehyde and 5% su-
crose for 15 min followed by washing and permeabilization in PBS with 
0.1% Triton X-100 for 5 min. The samples were blocked in PBS with 2% 
BSA and incubated with primary antibodies for 1 h. Primary antibodies 
were used as follows: rabbit anti-SIRT2 (1:500), mouse anti-SIRT2 (1:50; 
Santa Cruz Biotechnology, Inc.), rabbit anti-p35 (1:50; Santa Cruz Bio-
technology, Inc.), mouse anti  –       -tubulin (1:1,500; Sigma-Aldrich), and 
mouse anti  –  acetylated      -tubulin (1:1,500). Secondary antibodies conju-
gated to Alexa488, 546, or 660 (1:1,000; Invitrogen) were applied for 1 h 
along with Texas red phalloidin (Invitrogen) to highlight ﬁ  lamentous actin. 
After washing with PBS and staining with DAPI for 5 min, coverslips were 
mounted with mowiol. Images of cells were acquired at room temperature 
on a microscope (Axiovert; Carl Zeiss, Inc.) using either a 20  ×   Plan-Neo-
ﬂ  uar 0.5 NA (Carl Zeiss, Inc.) or a 63  ×   Plan-Neoﬂ  uar 1.3 NA (Carl Zeiss, 
Inc.) lens without oil. A camera (AxioCam; Carl, Zeiss Inc.) with AxioVision 
4.6 software (Carl Zeiss, Inc.) for deconvolution and Photoshop CS (Adobe) 
for adjusting contrast and brightness was used. 
  Colocalization of SIRT2 and p35 expression was performed by ana-
lyzing z stacks using AxioVision 4.6 software. Fig. S5 D is a typical result 
obtained from one individual section of the z-stack series. Fields 1 and 2 
contain pixels of SIRT2 and p35, respectively, not colocalizing, whereas 
area 3 reveals pixels overlapping (area 4 contains largely background 
signals surrounding the cells; Fig. S5 D). 
  Neurite outgrowth and growth cone collapse assays 
  Acid-treated coverslips (diameter, 13 mm) were coated with 100   μ  g/ml 
poly-  L  -lysine (Sigma-Aldrich) in borate buffer at 37  °  C for 1 h, followed by 
washing and incubating with 20   μ  g/ml mouse laminin (Invitrogen) in HBSS 
at 37  °  C for 3  –  4 h. After additional washing steps, coverslips were kept in 
DME with 10% HS at 37  °  C until used. Neurons were plated at a density of 
5   ×   10 
3         2   ×   10 
4   cells per coverslip and stained after 2 d of in vitro cul-
ture. For growth cone collapse assays, 2-d-old cultures were incubated at 
37  °  C for 30 min with 1   μ  g/ml of preclustered ephrin-A5-Fc with 10   μ  g/ml 
anti  –  human IgG, Fc-speciﬁ  c, for 30 min (Sigma-Aldrich) or Fc alone fol-
lowed by staining for F-actin and microtubules. 
H1, respectively. 1 catal of cyclin  –  Cdk activity incorporates 1 mol/s of 
phosphate in 30   μ  l of kinase buffer (50 mM Hepes, pH 7.5, 10 mM 
MgCl  2  , 0.01% Tween-20, 10 mM NaF, 10 mM      -glycerophosphate, 1 mM 
orthovanadate, 0.01% BSA, and 25   μ  M ATP) containing 5   μ  g pRb 
778-928   or 
histone H1 and 25   μ  M ATP. The incorporation of phosphate was linear 
over the incubation time of 30 min. The p35  –  Cdk5 complex was obtained 
from Millipore. 
  Solid phase phosphorylation 
  High-density protein arrays enriched for high expression of His  6  -tagged 
proteins were obtained from the German Resource Center for Genome Re-
search (hEx1 library; http://www.rzpd.de). For phosphorylation cloning, 
ﬁ  lters were rehydrated and the cell debris was washed off twice in 20 mM 
Tris-Cl, pH 7.5, 0.5 M NaCl, and 0.5% Tween-20 for 10 min each. Further 
processing steps were three incubations in 20 mM Tris-Cl, pH 7.5, 0.5 M 
NaCl, 20 mM Tris-Cl, pH 7.5, 0.5% Tween-20, 10 mM EDTA, 1 mM EGTA, 
1 mM DTT, 0.2 mM PMSF, and 3% BSA for 10 min each. Filters were 
brieﬂ  y equilibrated in kinase buffer and then incubated in the same buffer 
at room temperature for 1 h. Next, the ﬁ  lters were subjected to phosphory-
lation by incubation in kinase buffer supplemented with 2.5 pcatal/ml cy-
clin E  –  Cdk2 and 200 kBq/ml      -[ 
32  P]ATP at 30  °  C for 90 min. Finally, ﬁ  lters 
were washed in 50 mM Hepes, pH 7.5, 10 mM MgCl  2  , 250 mM NaCl, 
and 0.2 mM PMSF and exposed to x-ray ﬁ  lm for autoradiography. 
  In vitro kinase assays, in vivo labeling, and phosphatase assays 
  In vitro phosphorylation of puriﬁ  ed GST fusion proteins was performed as 
described previously (  Sarcevic et al., 1997  ), except that incubations were 
at 30  °  C for 30 min. For in vivo labeling, HEK293 cells were transiently 
transfected and, 2 d later, metabolically labeled in phosphate-free DME 
supplemented with 10% dialyzed FCS, 20 mM sodium bicarbonate, 18 mM 
Hepes, pH 7.5, and 10  –  20 MBq of [ 
32  P]orthophosphate for 2 h. The labeled 
cells were lysed in RIPA buffer. The HA-tagged SIRT2 proteins were immuno-
precipitated with      -HA mAb (3F10) and protein G  –  Agarose. The precipitates 
were washed four times in the same buffer and separated by SDS-PAGE on 
12% gels (  Luscher-Firzlaff et al., 2006  ). 
  For phosphatase treatment, cells were lysed in RIPA buffer and SIRT2 
was immunoprecipitated using polyclonal antisera and washed. Immobi-
lized proteins were resuspended in 50 mM Tris-HCl, pH 8.5, and 1 mM 
MgCl  2  . The probes were then incubated in the presence of 0.7 U of bacte-
rial alkaline phosphatase (Sigma-Aldrich) at 30  °  C for 30 min. The re  actions 
were stopped by adding SDS sample buffer. 
  Phosphopeptide identiﬁ  cation by nanoliquid chromatography tandem 
mass spectrometry 
  Proteins were treated with DTT and iodoacetamide and digested in gel by 
trypsin. Before nanoliquid chromatography tandem mass spectrometry 
analysis, all trypsin-digested samples were puriﬁ  ed and desalted using C  18   
STAGE tips (  Rappsilber et al., 2003  ). 
  Peptide identiﬁ   cation experiments were performed using a nano-
HPLC 1100 nanoﬂ  ow system (Agilent Technologies) connected online to a 
7-Tesla linear quadrupole ion trap  –  Fourier transform mass spectrometer 
(Thermo Fisher Scientiﬁ  c). Peptides were separated on 15 cm of 100   μ  m 
ID PicoTip columns (New Objective, Inc.) packed with 3   μ  m Reprosil C18 
beads (Dr. Maisch, GmbH) using a 90-min gradient from 90% buffer A/
10% buffer B to 65% buffer A/35% buffer B (buffer A contains 0.5% 
acetic acid and buffer B contains 80% acetonitrile in 0.5% acetic acid) 
with a ﬂ  ow rate of 300 nl/min. Peptides eluting from the column tip were 
electrosprayed directly into the mass spectrometer with a spray voltage of 
2.1 kV. The mass spectrometer was operated in the data-dependent mode 
to sequence the four most intense ions per duty cycle. In brief, full-scan 
mass spectrometry spectra of intact peptides (m/z 350  –  2,000) with an auto-
mated gain control accumulation target value of 10 
6   ions were acquired 
in the Fourier transform ion cyclotron resonance cell with a resolution of 
50,000. The four most abundant ions were sequentially isolated and frag-
mented in the linear ion trap by applying collision-induced dissociation us-
ing an accumulation target value of 20,000 (capillary temperature, 200  °  C; 
normalized collision energy, 30%). A dynamic exclusion of ions previously 
sequenced within 180 s was applied. All unassigned charge states were 
excluded from sequencing. A minimum of 500 counts was required for 
mass spectrometry 2 selection. Data-dependent neutral loss scanning of 
phosphoric acid groups was enabled for each mass spectrometry 2 spec-
trum among the three most intense fragment ions. 
  RAW spectrum ﬁ  les were converted into a Mascot generic peak list 
by DTASupercharge (http://msquant.sourceforge.net). Peptides and pro-
teins were identiﬁ  ed using the Mascot algorithm (Matrix Science) to search 
a local version of the UNIprot database (release 48.0). The following ini-JCB • VOLUME 180 • NUMBER 5 • 2008  928
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